Business
AstraZeneca Bristol Myers megadeal explorations
AstraZeneca has explored a potential megadeal to acquire Bristol Myers Squibb, a move described as creating one of the world’s largest drugmakers and valued…
AstraZeneca has explored a potential megadeal to acquire Bristol Myers Squibb, a move described as creating one of the world’s largest drugmakers and valued…
The AstraZeneca CSPC drug deal signifies a strategic move by AstraZeneca to expand its portfolio through acquisition of eight drug candidates from CSPC for